Catalent
CTLT
#1568
Rank
A$17.01 B
Marketcap
$93.76
Share price
2.21%
Change (1 day)
54.92%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Cash on Hand

Cash on Hand as of September 2024 : A$0.51 Billion

According to Catalent's latest financial reports the company has A$0.51 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalent - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30A$0.42 B-45.91%
2022-06-30A$0.78 B-39.24%
2021-06-30A$1.28 B-7.2%
2020-06-30A$1.38 B181.94%
2019-06-30A$0.49 B-11.23%
2018-06-30A$0.55 B38.75%
2017-06-30A$0.39 B115.23%
2016-06-30A$0.18 B-5.91%
2015-06-30A$0.19 B149.59%
2014-06-30A$79 M-32.13%
2013-06-30A$0.11 B-14.22%
2012-06-30A$0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.61 B 20.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.26 B-48.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.02 B 681.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$0.49 B-3.67%๐Ÿ‡บ๐Ÿ‡ธ USA